Lilly
Research Interests
Volunteers
Carrer With Us
 

Endocrine Disorders



  1. Exenatide pharmacokinetics in healthy Chinese subjects. Zhao X, Cui YM, Zhou Y, Zhang HL, Yeo KP, Linnebjerg H, Tham LS, Kothare P, Teng LL, Mace K, Soon D. Int J Clin Pharmacol Ther. 2008 Sep;46(9):459-65.

  2. Effect of upper respiratory tract infection on AIR inhaled insulin pharmacokinetics and glucodynamics in healthy subjects. Gern JE, Stone CK, Nakano M, Muchmore DB, de la Peña A, Park S, Suri A, Tibaldi F, Soon D, Busse WW. Clin Pharmacol Ther. 2008 Feb;83(2):307-11. Epub 2007 Jul 11.

  3. Effect of exenatide on the pharmacokinetics and pharmacodynamics of warfarin in healthy Asian men. Soon D, Kothare PA, Linnebjerg H, Park S, Yuen E, Mace KF, Wise SD. J Clin Pharmacol. 2006 Oct;46(10):1179-87.

  4. Effect of exenatide on the steady-state pharmacokinetics of digoxin. Kothare PA, Soon DK, Linnebjerg H, Park S, Chan C, Yeo A, Lim M, Mace KF, Wise SD. J Clin Pharmacol. 2005 Sep;45(9):1032-7.

  5. Insulin-like growth factor binding protein-1 is independently affected by ethnicity, insulin sensitivity, and leptin in healthy, glucose-tolerant young men. Liew CF, Wise SD, Yeo KP, Lee KO. J Clin Endocrinol Metab. 2005 Mar;90(3):1483-8. Epub 2004 Dec 14.

  6. Lean, nondiabetic Asian Indians have decreased insulin sensitivity and insulin clearance, and raised leptin compared to Caucasians and Chinese subjects. Liew CF, Seah ES, Yeo KP, Lee KO, Wise SD. Int J Obes Relat Metab Disord. 2003 Jul;27(7):784-9.